SEARCH PLATELETNEWS.ORG
Faculty

Peter B. Berger, MD

Co-Chair

Glenn N. Levine, MD

Co-Chair
Poll
question goes here

Educational Links
You need to upgrade your Flash Player
Current Literature

Search Literature Reviews

 Categories
Browse Alphabetically by Author
A-D E-H I-L M-P Q-T U-Z

Keywords



Influence of Aspirin Resistance on Platelet Function Profiles in Patients on Long-Term Aspirin and Clopidogrel After Percutaneous Coronary Intervention

Angiolillo et al.
Am J Cardiol.  2006;97:38-43.
 

Eptifibatide Provides Additional Platelet Inhibition in Non–ST-Elevation Myocardial Infarction Patients Already Treated With Aspirin and Clopidogrel: Results of the Platelet Activity Extinction in Non–Q-Wave Myocardial Infarction With Aspirin, Clopidogrel, and Eptifibatide (PEACE) Study

Dalby et al.
J Am Coll Cardiol.   2004;43:162-168.
 

Predictors and impact of major hemorrhage on mortality following percutaneous coronary intervention from the REPLACE-2 trial

Feit et al.
Am J Cardiol.  2007;100:1364-1369
 

Initial Experience With an Intravenous P2Y12 Platelet Receptor Antagonist in Patients Undergoing Percutaneous Coronary Intervention: Results From a 2-Part, Phase II, Multicenter, Randomized, Placebo- and Active-Controlled Trial

Greenbaum et al.
Am Heart J.   2006;151:689.e1-689.e10.
 

A Review of the Clopidogrel Loading With Eptifibatide to Arrest the Reactivity of Platelets (CLEAR PLATELETS) and CLEAR PLATELETS 1b Studies

Gurbel et al.
Circulation.   2005;111:1153-1159.
 

Clopidogrel Effect on Platelet Reactivity in Patients With Stent Thrombosis. Results of the CREST Study

Gurbel et al.
J Am Coll Cardiol .  2005;46:1827-1832.
 

Incidence of Death and Acute Myocardial Infarction Associated with Stopping Clopidogrel After Acute Coronary Syndrome

Ho PM et al.
JAMA.  2008;299:532-539.
 

Impact of the Degree of Peri-Interventional Platelet Inhibition After Loading With Clopidogrel on Early Clinical Outcome Of Elective Coronary Stent Placement

Hochholzer et al.
Am Coll Cardiol.   2006;48:1742-1750.
 

Antiplatelet Therapy in Children

Israels et al.
Thrombosis Res.  2006;118:75-83.
 

Aspirin and Clopidogrel Drug Response in Patients Undergoing Percutaneous Coronary Intervention

Lev et al.
J Am Coll Cardiol.  2006;47:27-33.
 

A Review of the Omeprazole Clopidogrel Aspirin (OCLA) Study

Martine Gilard et al.
J Am Coll Cardiol.   2008;51:256-260.
 

Aspirin Resistance: Current Concepts

Mason et al.
Rev Cardiovasc Med.  2004;5(3):156-163.
 

Acute Clopidogrel Use and Outcomes in Patients With Non-ST-Segment Elevation Acute Coronary Syndromes Undergoing Coronary Artery Bypass Surgery

Mehta et al.
J Am Coll Cardiol.  2006;48:281-286.
 

Comparing High Clopidogrel Loading Doses in Non-ST-Segment Elevation ACS Patients

Montalescot et al.
J Am Coll Cardiol.   2006;48:931-938.
 

Drug-Eluting Stent Thrombosis. Results From a Pooled Analysis Including 10 Randomized Studies

Moreno et al.
J Am Coll Cardiol.   2005;45:954-959.
 

A Review of the Different Methodolgies for Evaluation the Effect of Clopidogrel on Platelet Function in High-Risk Coronary Disease Patients

Paniccia et al.
Thromb Haemost.  2007;5:1839-1847.
 

Variability in Platelet Responsiveness to Clopidogrel Among 544 Individuals

Serebruany et al.
J Am Coll Cardiol.   2005;45:246-251.
 

Thrombogenic Risk Factors for Atherothrombosis

Shah.
Rev Cardiovasc Med.  2004;5(3):156-163.
 

Optimal Timing for the Initiation of Pre-Treatment With 300 mg Clopidogrel Before Percutaneous Coronary Intervention

Steinhubl et al.
J Am Coll Cardiol.   2006;47:939-943.
 

A Review of the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the American College of Cardiology/American Heart Association Guidelines (CRUSADE) Trial

Tricoci et al.
Am J Cardiol.  2007;99:1389-1393.
 

Efficacy and Safety of Triple Antiplatelet Therapy With and Without Concomitant Anticoagulation During Elective Percutaneous Coronary Intervention (The REMOVE Trial)

Valencia et al.
Am J Cardiol.  2007 Oct 1;100(7):1099-1102.
 

A Review of the Intracoronary Stenting and Antithrombotic Regimen–Choose a High Oral Maintenance Dose for Intensified Clopidogrel Effect (ISAR–CHOICE-2) and Optimizing Antiplatelet Therapy in Diabetes Mellitus (OPTIMUS) Studies

von Beckerath et al.
Eur Heart J.  2007 Feb 1; [Epub ahead of print].
 

Prasugrel Compared With High Loading- and Maintenance-Dose Clopidogrel in Patients with Planned Percutaneous Coronary Intervention: The Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myocardial Infarction 44 Trial

Wiviott et al.
Circulation.  2007;116:2923-2932.
 


back to the top